US Equity
CRSP
— CRISPR Therapeutics LtdCRISPR Therapeutics is a gene editing company that develops transformative gene-based medicines using its proprietary CRISPR/Cas9 platform for severe diseases.
💰 Market cap: $4.51B📍 Baarerstrasse 14, ZUG, ZUG, 6300 CH🏷️ Biotechnology & Medical Research💵 Previous close: $46.54🔢 5,740 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $46.54 |
| 2026-07-23 | $47.53 |
| 2026-07-22 | $47.24 |
| 2026-07-21 | $48.15 |
| 2026-07-20 | $46.99 |
| 2026-07-17 | $47.78 |
| 2026-07-16 | $48.57 |
| 2026-07-15 | $51.37 |
| 2026-07-14 | $50.46 |
| 2026-07-13 | $50.63 |
| 2026-07-10 | $53.35 |
| 2026-07-09 | $56.34 |
| 2026-07-08 | $59.20 |
| 2026-07-07 | $60.77 |
| 2026-07-06 | $61.89 |
| 2026-07-02 | $60.08 |
| 2026-07-01 | $55.62 |
| 2026-06-30 | $54.54 |
| 2026-06-29 | $56.35 |
| 2026-06-26 | $54.92 |
| 2026-06-25 | $53.98 |
| 2026-06-24 | $53.55 |
| 2026-06-23 | $53.99 |
| 2026-06-22 | $54.36 |
| 2026-06-18 | $54.09 |
| 2026-06-17 | $53.09 |
| 2026-06-16 | $52.02 |
| 2026-06-15 | $52.61 |
| 2026-06-12 | $49.80 |
| 2026-06-11 | $50.23 |
| 2026-06-10 | $49.44 |
| 2026-06-09 | $51.48 |
| 2026-06-08 | $51.60 |
| 2026-06-05 | $51.84 |
| 2026-06-04 | $56.95 |
| 2026-06-03 | $52.08 |
| 2026-06-02 | $52.02 |
| 2026-06-01 | $54.19 |
| 2026-05-29 | $56.18 |
| 2026-05-28 | $56.38 |
| 2026-05-27 | $53.53 |
| 2026-05-26 | $51.59 |
| 2026-05-22 | $50.36 |
| 2026-05-21 | $49.90 |
| 2026-05-20 | $48.55 |
| 2026-05-19 | $47.59 |
| 2026-05-18 | $48.56 |
| 2026-05-15 | $48.41 |
| 2026-05-14 | $50.45 |
| 2026-05-13 | $52.75 |
| 2026-05-12 | $52.83 |
| 2026-05-11 | $54.01 |
| 2026-05-08 | $54.83 |
| 2026-05-07 | $52.42 |
| 2026-05-06 | $55.08 |
| 2026-05-05 | $52.38 |
| 2026-05-04 | $53.58 |
| 2026-05-01 | $51.63 |
| 2026-04-30 | $52.34 |
| 2026-04-29 | $50.71 |
| 2026-04-28 | $52.06 |